Powered by OpenAIRE graph
Found an issue? Give us feedback
ZENODOarrow_drop_down
ZENODO
Journal . 2024
License: CC BY
Data sources: Datacite
ZENODO
Journal . 2024
License: CC BY
Data sources: Datacite
versions View all 2 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

ARTIFICIAL INTELLIGENCE: AN EVOLVING TOOL IN PHARMACEUTICAL PRODUCT DEVELOPMENT

Authors: Imran A. W. Sheikh*, Swati K. Kaikade*, Payal S. Selukar, Pranay G. Khobragade;

ARTIFICIAL INTELLIGENCE: AN EVOLVING TOOL IN PHARMACEUTICAL PRODUCT DEVELOPMENT

Abstract

Artificial intelligence's usage in pharmaceutical technology has grown over time, and it may save time and money while offering a greater knowledge of the interactions between different formulations and process factors. Artificial intelligence is an area of computer science concerned with problem solving through the use of symbolic programming. Artificial intelligence (AI) employs personalized knowledge and learns from the solutions it generates to handle both particular and complex issues. Remarkable developments in processing power, along with advances in AI technology, have the potential to transform the drug development process. The pharmaceutical sector is now facing difficulty in continuing drug development programs due to higher R&D expenses and decreased efficiency. Artificial Neural Network (ANN) technologies are being developed for predicting relationships in data.Machine learning and deep learning are also being used to examine various machine parameters and regulate them accordingly to get the desired results.Thus, Artificial Intelligence programs serve as effective solutions for creating a medicinal product. They are also utilized in clinical studies to generate and evaluate data collected from patient information. As a result, in this article, we will discuss several applications of artificial intelligence in pharmaceutical product development, providing a clear picture of how AI has an efficient influence on the pharmaceutical industry.

Keywords

Artificial Neural Networks, Recurrent Neural Networks, Drug repurposing, Clinical Trails, Polypharmacology, Physiologically Based Pharmacokinetic.

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average